Optimizing Wilms tumor 1 thresholds for measurable residual disease monitoring in acute myeloid leukemia: Improved sensitivity and concordance with nucleophosmin 1 in a single‐center validation study
Sabrina Barrière, Céline Bourgne, Thomas Tassin, Anais Establie et autres
fr (code pays fourni par la source)
1 citation
Cancer